Global Tacrolimus Industry Outlook 2022: Overview, Opportunities, Key Companies and Forecast to 2028
- Category: Healthcare
- Published Date: Dec 2021
- Publisher: GRD Survey
- Pages: 153
Executive Summary
According to GRD Survey data, the global Tacrolimus market is estimated at million US$ in 2021 and is expected to reach million US$ by the end of 2028, growing at a CAGR of % in the forecast period between 2022 and 2028.
This report studies the Tacrolimus market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Tacrolimus in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)
Market Snapshot, By Product Type
Tacrolimus Capsules
Tacrolimus Ointment
Tacrolimus Injection
Market Snapshot, By Application
Hospitals
Clinics
Other
Main Market Players Analyzed in this report, including:
GSK
Zhongmei Huadong Pharmaceutical
Yamanouchi Pharmaceutical
Tecoland
Takeda
Suzhou Pharmaceutical Technology
Squibb
Sinopharm Chuankang Pharmaceutical
Sichuan Med-Shine Pharmaceutical
Senju Pharmaceutical
ScinoPharm
Sandoz
RPG Life Science
Roche Pharma
Novartis
Mylan
Huapont Pharma
Hisun Pharmaceutical
Guike Pharmaceutical
Fujisawa Pharmaceutical
Astellas
Accura Pharmaceuticals
Abbott
Aarti Group
The study objectives of this report are:
To study and analyze the global Tacrolimus market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Tacrolimus market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Tacrolimus manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Tacrolimus market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Tacrolimus submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Tacrolimus are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027
This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries
According to GRD Survey data, the global Tacrolimus market is estimated at million US$ in 2021 and is expected to reach million US$ by the end of 2028, growing at a CAGR of % in the forecast period between 2022 and 2028.
This report studies the Tacrolimus market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Tacrolimus in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)
Market Snapshot, By Product Type
Tacrolimus Capsules
Tacrolimus Ointment
Tacrolimus Injection
Market Snapshot, By Application
Hospitals
Clinics
Other
Main Market Players Analyzed in this report, including:
GSK
Zhongmei Huadong Pharmaceutical
Yamanouchi Pharmaceutical
Tecoland
Takeda
Suzhou Pharmaceutical Technology
Squibb
Sinopharm Chuankang Pharmaceutical
Sichuan Med-Shine Pharmaceutical
Senju Pharmaceutical
ScinoPharm
Sandoz
RPG Life Science
Roche Pharma
Novartis
Mylan
Huapont Pharma
Hisun Pharmaceutical
Guike Pharmaceutical
Fujisawa Pharmaceutical
Astellas
Accura Pharmaceuticals
Abbott
Aarti Group
The study objectives of this report are:
To study and analyze the global Tacrolimus market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Tacrolimus market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Tacrolimus manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Tacrolimus market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Tacrolimus submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Tacrolimus are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027
This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries
Table of Contents
1 Market Definition & Scope
1.1 Definition & Scope
1.2 Tacrolimus Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Tacrolimus Market Performance and Outlook
2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter’s Five Forces Analysis
2.3 Comparison of Alternatives and Tacrolimus
3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 Tacrolimus Sales Channel and Distributors Analysis
3.3.1 Tacrolimus Sales Channel
3.3.2 Tacrolimus Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in Hospitals
3.4.2 Major Buyers in Clinics
3.5 Tacrolimus Manufacturing Cost Structure Analysis
4 Market Segment: by Type
4.1 Tacrolimus Type Introduction
4.1.1 Tacrolimus Capsules
4.1.2 Tacrolimus Ointment
4.1.3 Tacrolimus Injection
4.2 Global Tacrolimus Sales by Type 2016-2021
4.3 Global Tacrolimus Revenue by Type 2016-2021
4.4 Global Tacrolimus Price by Type 2016-2021
5 Market Segment: by Application
5.1 Tacrolimus Type Introduction
5.1.1 Hospitals
5.1.2 Clinics
5.1.3 Other
5.2 Global Tacrolimus Sales by Application 2016-2021
5.3 Global Tacrolimus Revenue by Application 2016-2021
5.4 Global Tacrolimus Price by Application 2016-2021
6 Marke Segment: by Region
6.1 Global Tacrolimus Market by Region
6.1.1 Global Tacrolimus Sales by Regions
6.1.2 Global Tacrolimus Revenue by Regions
6.2 North America Tacrolimus Market 2016-2021
6.3 Europe Tacrolimus Market 2016-2021
6.4 Asia Pacific Tacrolimus Market 2016-2021
6.5 South America Tacrolimus Market 2016-2021
6.6 Middle East and Africa Tacrolimus Market 2016-2021
7 North America
7.1 North America Tacrolimus Market by Country 2016-2021
7.1.1 North America Tacrolimus Sales by Country
7.1.2 North America Tacrolimus Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico
8 Europe
8.1 Europe Tacrolimus Market by Country 2016-2021
8.1.1 Europe Tacrolimus Sales by Country
8.1.2 Europe Tacrolimus Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain
9 Asia Pacific
9.1 Asia Pacific Tacrolimus Market by Country 2016-2021
9.1.1 Asia Pacific Tacrolimus Sales by Country
9.1.2 Asia Pacific Tacrolimus Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia
10 South America
10.1 South America Tacrolimus Market by Country 2016-2021
10.1.1 South America Tacrolimus Sales by Country
10.1.2 South America Tacrolimus Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Tacrolimus Market by Country 2016-2021
11.1.1 Middle East and Africa Tacrolimus Sales by Country
11.1.2 Middle East and Africa Tacrolimus Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa
12 Key Participants Company Information
12.1 GSK
12.1.1 GSK Company Information
12.1.2 GSK Tacrolimus Product Portfolio, Specification and Application
12.1.3 GSK Tacrolimus Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 GSK Key Development
12.2 Zhongmei Huadong Pharmaceutical
12.2.1 Zhongmei Huadong Pharmaceutical Company Information
12.2.2 Zhongmei Huadong Pharmaceutical Tacrolimus Product Portfolio, Specification and Application
12.2.3 Zhongmei Huadong Pharmaceutical Tacrolimus Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 Zhongmei Huadong Pharmaceutical Key Development
12.3 Yamanouchi Pharmaceutical
12.3.1 Yamanouchi Pharmaceutical Company Information
12.3.2 Yamanouchi Pharmaceutical Tacrolimus Product Portfolio, Specification and Application
12.3.3 Yamanouchi Pharmaceutical Tacrolimus Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 Yamanouchi Pharmaceutical Key Development
12.4 Tecoland
12.4.1 Tecoland Company Information
12.4.2 Tecoland Tacrolimus Product Portfolio, Specification and Application
12.4.3 Tecoland Tacrolimus Sales, Price, Revenue and Gross Margin (2019-2021)
12.4.4 Tecoland Key Development
12.5 Takeda
12.5.1 Takeda Company Information
12.5.2 Takeda Tacrolimus Product Portfolio, Specification and Application
12.5.3 Takeda Tacrolimus Sales, Price, Revenue and Gross Margin (2019-2021)
12.5.4 Takeda Key Development
12.6 Suzhou Pharmaceutical Technology
12.6.1 Suzhou Pharmaceutical Technology Company Information
12.6.2 Suzhou Pharmaceutical Technology Tacrolimus Product Portfolio, Specification and Application
12.6.3 Suzhou Pharmaceutical Technology Tacrolimus Sales, Price, Revenue and Gross Margin (2019-2021)
12.6.4 Suzhou Pharmaceutical Technology Key Development
12.7 Squibb
12.7.1 Squibb Company Information
12.7.2 Squibb Tacrolimus Product Portfolio, Specification and Application
12.7.3 Squibb Tacrolimus Sales, Price, Revenue and Gross Margin (2019-2021)
12.7.4 Suzhou Pharmaceutical Technology Key Development
12.9 Sichuan Med-Shine Pharmaceutical
12.9.1 Sichuan Med-Shine Pharmaceutical Company Information
12.9.2 Sichuan Med-Shine Pharmaceutical Tacrolimus Product Portfolio, Specification and Application
12.9.3 Sichuan Med-Shine Pharmaceutical Tacrolimus Sales, Price, Revenue and Gross Margin (2019-2021)
12.9.4 Sichuan Med-Shine Pharmaceutical Key Development
12.8 Sinopharm Chuankang Pharmaceutical
12.8.1 Sinopharm Chuankang Pharmaceutical Company Information
12.8.2 Sinopharm Chuankang Pharmaceutical Tacrolimus Product Portfolio, Specification and Application
12.8.3 Sinopharm Chuankang Pharmaceutical Tacrolimus Sales, Price, Revenue and Gross Margin (2019-2021)
12.8.4 Sinopharm Chuankang Pharmaceutical Key Development
12.11 ScinoPharm
12.11.1 ScinoPharm Company Information
12.11.2 ScinoPharm Tacrolimus Product Portfolio, Specification and Application
12.11.3 ScinoPharm Tacrolimus Sales, Price, Revenue and Gross Margin (2019-2021)
12.11.4 ScinoPharm Key Development
12.12 Sandoz
12.12.1 Sandoz Company Information
12.12.2 Sandoz Tacrolimus Product Portfolio, Specification and Application
12.12.3 Sandoz Tacrolimus Sales, Price, Revenue and Gross Margin (2019-2021)
12.12.4 Sandoz Key Development
12.13 RPG Life Science
12.13.1 RPG Life Science Company Information
12.13.2 RPG Life Science Tacrolimus Product Portfolio, Specification and Application
12.13.3 RPG Life Science Tacrolimus Sales, Price, Revenue and Gross Margin (2019-2021)
12.13.4 RPG Life Science Key Development
12.14 Roche Pharma
12.14.1 Roche Pharma Company Information
12.14.2 Roche Pharma Tacrolimus Product Portfolio, Specification and Application
12.14.3 Roche Pharma Tacrolimus Sales, Price, Revenue and Gross Margin (2019-2021)
12.14.4 Roche Pharma Key Development
12.15 Novartis
12.15.1 Novartis Company Information
12.15.2 Novartis Tacrolimus Product Portfolio, Specification and Application
12.15.3 Novartis Tacrolimus Sales, Price, Revenue and Gross Margin (2019-2021)
12.15.4 Novartis Key Development
12.17 Huapont Pharma
12.18 Hisun Pharmaceutical
12.19 Guike Pharmaceutical
12.20 Fujisawa Pharmaceutical
12.21 Astellas
12.22 Accura Pharmaceuticals
12.23 Abbott
12.24 Aarti Group
13 Global Tacrolimus Market Forecast by Region by Type and by Application
13.1 Global Tacrolimus Sales, Revenue Forecast 2022-2027
13.2 Global Tacrolimus Forecast by Regions
13.2.1 Global Tacrolimus Sales Forecast by Region 2022-2027
13.2.2 Global Tacrolimus Revenue Forecast by Region 2022-2027
13.3 Global Tacrolimus Forecast by Type
13.3.1 Global Tacrolimus Sales Forecast by Type 2022-2027
13.3.2 Global Tacrolimus Revenue Forecast by Type 2022-2027
13.3.3 Global Tacrolimus Price Forecast by Type 2022-2027
13.4 Global Tacrolimus Forecast by Application
13.4.1 Global Tacrolimus Sales Forecast by Application 2022-2027
13.4.2 Global Tacrolimus Revenue Forecast by Application 2022-2027
13.4.3 Global Tacrolimus Price Forecast by Application 2022-2027
14 Analyst Views and Conclusions
15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer
1 Market Definition & Scope
1.1 Definition & Scope
1.2 Tacrolimus Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Tacrolimus Market Performance and Outlook
2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter’s Five Forces Analysis
2.3 Comparison of Alternatives and Tacrolimus
3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 Tacrolimus Sales Channel and Distributors Analysis
3.3.1 Tacrolimus Sales Channel
3.3.2 Tacrolimus Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in Hospitals
3.4.2 Major Buyers in Clinics
3.5 Tacrolimus Manufacturing Cost Structure Analysis
4 Market Segment: by Type
4.1 Tacrolimus Type Introduction
4.1.1 Tacrolimus Capsules
4.1.2 Tacrolimus Ointment
4.1.3 Tacrolimus Injection
4.2 Global Tacrolimus Sales by Type 2016-2021
4.3 Global Tacrolimus Revenue by Type 2016-2021
4.4 Global Tacrolimus Price by Type 2016-2021
5 Market Segment: by Application
5.1 Tacrolimus Type Introduction
5.1.1 Hospitals
5.1.2 Clinics
5.1.3 Other
5.2 Global Tacrolimus Sales by Application 2016-2021
5.3 Global Tacrolimus Revenue by Application 2016-2021
5.4 Global Tacrolimus Price by Application 2016-2021
6 Marke Segment: by Region
6.1 Global Tacrolimus Market by Region
6.1.1 Global Tacrolimus Sales by Regions
6.1.2 Global Tacrolimus Revenue by Regions
6.2 North America Tacrolimus Market 2016-2021
6.3 Europe Tacrolimus Market 2016-2021
6.4 Asia Pacific Tacrolimus Market 2016-2021
6.5 South America Tacrolimus Market 2016-2021
6.6 Middle East and Africa Tacrolimus Market 2016-2021
7 North America
7.1 North America Tacrolimus Market by Country 2016-2021
7.1.1 North America Tacrolimus Sales by Country
7.1.2 North America Tacrolimus Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico
8 Europe
8.1 Europe Tacrolimus Market by Country 2016-2021
8.1.1 Europe Tacrolimus Sales by Country
8.1.2 Europe Tacrolimus Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain
9 Asia Pacific
9.1 Asia Pacific Tacrolimus Market by Country 2016-2021
9.1.1 Asia Pacific Tacrolimus Sales by Country
9.1.2 Asia Pacific Tacrolimus Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia
10 South America
10.1 South America Tacrolimus Market by Country 2016-2021
10.1.1 South America Tacrolimus Sales by Country
10.1.2 South America Tacrolimus Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Tacrolimus Market by Country 2016-2021
11.1.1 Middle East and Africa Tacrolimus Sales by Country
11.1.2 Middle East and Africa Tacrolimus Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa
12 Key Participants Company Information
12.1 GSK
12.1.1 GSK Company Information
12.1.2 GSK Tacrolimus Product Portfolio, Specification and Application
12.1.3 GSK Tacrolimus Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 GSK Key Development
12.2 Zhongmei Huadong Pharmaceutical
12.2.1 Zhongmei Huadong Pharmaceutical Company Information
12.2.2 Zhongmei Huadong Pharmaceutical Tacrolimus Product Portfolio, Specification and Application
12.2.3 Zhongmei Huadong Pharmaceutical Tacrolimus Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 Zhongmei Huadong Pharmaceutical Key Development
12.3 Yamanouchi Pharmaceutical
12.3.1 Yamanouchi Pharmaceutical Company Information
12.3.2 Yamanouchi Pharmaceutical Tacrolimus Product Portfolio, Specification and Application
12.3.3 Yamanouchi Pharmaceutical Tacrolimus Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 Yamanouchi Pharmaceutical Key Development
12.4 Tecoland
12.4.1 Tecoland Company Information
12.4.2 Tecoland Tacrolimus Product Portfolio, Specification and Application
12.4.3 Tecoland Tacrolimus Sales, Price, Revenue and Gross Margin (2019-2021)
12.4.4 Tecoland Key Development
12.5 Takeda
12.5.1 Takeda Company Information
12.5.2 Takeda Tacrolimus Product Portfolio, Specification and Application
12.5.3 Takeda Tacrolimus Sales, Price, Revenue and Gross Margin (2019-2021)
12.5.4 Takeda Key Development
12.6 Suzhou Pharmaceutical Technology
12.6.1 Suzhou Pharmaceutical Technology Company Information
12.6.2 Suzhou Pharmaceutical Technology Tacrolimus Product Portfolio, Specification and Application
12.6.3 Suzhou Pharmaceutical Technology Tacrolimus Sales, Price, Revenue and Gross Margin (2019-2021)
12.6.4 Suzhou Pharmaceutical Technology Key Development
12.7 Squibb
12.7.1 Squibb Company Information
12.7.2 Squibb Tacrolimus Product Portfolio, Specification and Application
12.7.3 Squibb Tacrolimus Sales, Price, Revenue and Gross Margin (2019-2021)
12.7.4 Suzhou Pharmaceutical Technology Key Development
12.9 Sichuan Med-Shine Pharmaceutical
12.9.1 Sichuan Med-Shine Pharmaceutical Company Information
12.9.2 Sichuan Med-Shine Pharmaceutical Tacrolimus Product Portfolio, Specification and Application
12.9.3 Sichuan Med-Shine Pharmaceutical Tacrolimus Sales, Price, Revenue and Gross Margin (2019-2021)
12.9.4 Sichuan Med-Shine Pharmaceutical Key Development
12.8 Sinopharm Chuankang Pharmaceutical
12.8.1 Sinopharm Chuankang Pharmaceutical Company Information
12.8.2 Sinopharm Chuankang Pharmaceutical Tacrolimus Product Portfolio, Specification and Application
12.8.3 Sinopharm Chuankang Pharmaceutical Tacrolimus Sales, Price, Revenue and Gross Margin (2019-2021)
12.8.4 Sinopharm Chuankang Pharmaceutical Key Development
12.11 ScinoPharm
12.11.1 ScinoPharm Company Information
12.11.2 ScinoPharm Tacrolimus Product Portfolio, Specification and Application
12.11.3 ScinoPharm Tacrolimus Sales, Price, Revenue and Gross Margin (2019-2021)
12.11.4 ScinoPharm Key Development
12.12 Sandoz
12.12.1 Sandoz Company Information
12.12.2 Sandoz Tacrolimus Product Portfolio, Specification and Application
12.12.3 Sandoz Tacrolimus Sales, Price, Revenue and Gross Margin (2019-2021)
12.12.4 Sandoz Key Development
12.13 RPG Life Science
12.13.1 RPG Life Science Company Information
12.13.2 RPG Life Science Tacrolimus Product Portfolio, Specification and Application
12.13.3 RPG Life Science Tacrolimus Sales, Price, Revenue and Gross Margin (2019-2021)
12.13.4 RPG Life Science Key Development
12.14 Roche Pharma
12.14.1 Roche Pharma Company Information
12.14.2 Roche Pharma Tacrolimus Product Portfolio, Specification and Application
12.14.3 Roche Pharma Tacrolimus Sales, Price, Revenue and Gross Margin (2019-2021)
12.14.4 Roche Pharma Key Development
12.15 Novartis
12.15.1 Novartis Company Information
12.15.2 Novartis Tacrolimus Product Portfolio, Specification and Application
12.15.3 Novartis Tacrolimus Sales, Price, Revenue and Gross Margin (2019-2021)
12.15.4 Novartis Key Development
12.17 Huapont Pharma
12.18 Hisun Pharmaceutical
12.19 Guike Pharmaceutical
12.20 Fujisawa Pharmaceutical
12.21 Astellas
12.22 Accura Pharmaceuticals
12.23 Abbott
12.24 Aarti Group
13 Global Tacrolimus Market Forecast by Region by Type and by Application
13.1 Global Tacrolimus Sales, Revenue Forecast 2022-2027
13.2 Global Tacrolimus Forecast by Regions
13.2.1 Global Tacrolimus Sales Forecast by Region 2022-2027
13.2.2 Global Tacrolimus Revenue Forecast by Region 2022-2027
13.3 Global Tacrolimus Forecast by Type
13.3.1 Global Tacrolimus Sales Forecast by Type 2022-2027
13.3.2 Global Tacrolimus Revenue Forecast by Type 2022-2027
13.3.3 Global Tacrolimus Price Forecast by Type 2022-2027
13.4 Global Tacrolimus Forecast by Application
13.4.1 Global Tacrolimus Sales Forecast by Application 2022-2027
13.4.2 Global Tacrolimus Revenue Forecast by Application 2022-2027
13.4.3 Global Tacrolimus Price Forecast by Application 2022-2027
14 Analyst Views and Conclusions
15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer
no record found